These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32855879)

  • 1. PnPP-19 Peptide as a Novel Drug Candidate for Topical Glaucoma Therapy Through Nitric Oxide Release.
    da Silva CN; Dourado LFN; de Lima ME; da Silva Cunha-Jr A
    Transl Vis Sci Technol; 2020 Jul; 9(8):33. PubMed ID: 32855879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PnPP-19 Peptide Restores Erectile Function in Hypertensive and Diabetic Animals Through Intravenous and Topical Administration.
    Nunes da Silva C; Nunes KP; De Marco Almeida F; Silva Costa FL; Borges PV; Lacativa P; Pimenta AMC; Elena de Lima M
    J Sex Med; 2019 Mar; 16(3):365-374. PubMed ID: 30773502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-donating compounds for IOP lowering in glaucoma.
    Andrés-Guerrero V; García-Feijoo J
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Jun; 93(6):290-299. PubMed ID: 29580758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.
    Silva CN; Nunes KP; Torres FS; Cassoli JS; Santos DM; Almeida Fde M; Matavel A; Cruz JS; Santos-Miranda A; Nunes AD; Castro CH; Machado de Ávila RA; Chávez-Olórtegui C; Láuar SS; Felicori L; Resende JM; Camargos ER; Borges MH; Cordeiro MN; Peigneur S; Tytgat J; de Lima ME
    J Urol; 2015 Nov; 194(5):1481-90. PubMed ID: 26119670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the PnTx2-6 Toxin to the PnPP-19 Engineered Peptide: Therapeutic Potential in Erectile Dysfunction, Nociception, and Glaucoma.
    da Silva CN; Nunes KP; Dourado LFN; Vieira TO; Mariano XM; Cunha Junior ADS; de Lima ME
    Front Mol Biosci; 2022; 9():831823. PubMed ID: 35480885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/K
    Freitas AC; Silva GC; Pacheco DF; Pimenta AM; Lemos VS; Duarte ID; de Lima ME
    Nitric Oxide; 2017 Apr; 64():31-38. PubMed ID: 28087360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma.
    Giuffrida S; Bucolo C; Drago F
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):527-34. PubMed ID: 14733710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
    Morrison JC; Nylander KB; Lauer AK; Cepurna WO; Johnson E
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):526-31. PubMed ID: 9501862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application of Nitric Oxide for Ocular Hypertension Treatment.
    Han B; Song M; Li L; Sun X; Lei Y
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model.
    Galassi F; Masini E; Giambene B; Fabrizi F; Uliva C; Bolla M; Ongini E
    Br J Ophthalmol; 2006 Nov; 90(11):1414-9. PubMed ID: 16914472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporary elevation of the intraocular pressure by cauterization of vortex and episcleral veins in rats causes functional deficits in the retina and optic nerve.
    Grozdanic SD; Betts DM; Sakaguchi DS; Kwon YH; Kardon RH; Sonea IM
    Exp Eye Res; 2003 Jul; 77(1):27-33. PubMed ID: 12823985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
    Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
    Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
    Serle JB; Podos SM; Kitazawa Y; Wang RF
    Jpn J Ophthalmol; 1998; 42(2):95-100. PubMed ID: 9587840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
    Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WK; Gale DC; Kucera DJ; Jia L; Prasanna G; Ongini E; Krauss AH; Impagnatiello F
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):125-32. PubMed ID: 20415621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Peptide PnPP-19, a Spider Toxin Derivative, Activates μ-Opioid Receptors and Modulates Calcium Channels.
    Freitas ACN; Peigneur S; Macedo FHP; Menezes-Filho JE; Millns P; Medeiros LF; Arruda MA; Cruz J; Holliday ND; Tytgat J; Hathway G; de Lima ME
    Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29342943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide donating anti-glaucoma drugs: advances and prospects.
    Mao YJ; Wu JB; Yang ZQ; Zhang YH; Huang ZJ
    Chin J Nat Med; 2020 Apr; 18(4):275-283. PubMed ID: 32402405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.